i neglectful linking number interesting stories compadres blogging world limited attempt catch pfizer wants pry confidential peer reviews away new england journal medicine utterly ridiculous pfizer facing pile lawsuits hoping peer reviewer might said something nice products bextra celebrex peer review could try use legal defense reeks desperation pharmagossip notes astrazeneca cool million medicaid drug price fraud alabama sheesh hear certain politicians talk show hosts decry called welfare queens would appear astrazeneca real welfare queen aubrey blumsohn fine sarcastic bit fred hassan meanwhile british medical journal advertising watch continues philip dawdy lays smack judith warner new york times regarding overmedicated kids ex gsk ceo jean pierre garnier officially delusional ca stand company judged meanies media seem ignore science proclaims gsk products wonderful worry garnier still hero atypical antipsychotics notes whoopee vanda pharmaceuticals finally submitted application iloperidone best part apparently drunker skunk vanda opted name drug fiapta possibly lamest name yet prescription drug i thought previously drug looks like flop see i right note article published stated clinical trials iloperidone underway i find single published clinical trial drug seem strange anyone else daniel carlat notes lilly concocted article put smiley face cymbalta heparin chinese pigs needs supervision high ceo pay little accountability yuck story health care renewal fun read check pharma giles places usual brand sarcasm onto new fda guidelines would allow drug companies engage label promotion guise science next week expect post ceaseless marketing effexor researchers editorial assistants used combination small advantage effexor drugs combination soft endpoint make case effexor advantageous improve public health